The invention is concerned with novel N-(4-carbamimidoyl-phenyl)-glycine
derivatives of the formula:
##STR1##
wherein R.sup.1, E, X.sup.1 to X.sup.4 and G.sup.1 and G.sup.2 are as
defined in the description and the claims, as well as hydrates or solvates
and physiologically usable salts thereof.